SGMO
Sangamo Therapeutics Inc
NASDAQ: SGMO · HEALTHCARE · BIOTECHNOLOGY
$0.12
-10.24% today
Updated 2026-04-30
Market cap
$78.75M
P/E ratio
—
P/S ratio
1.99x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$0 – $1
Volume
7.8M
Sangamo Therapeutics Inc (SGMO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |